is retatrutide available UK 2026: Availability, Trial Results & Legal Status What To Know About Buying

Infusion therapy supports immune system health, not just short-term relief

One phase 3 clinical trial found that survodutide led to an average 12% to 18.7% body weight reduction , depending on dose, in adults with obesity and without diabetes after 76 weeks compared to 5% in the placebo group

At baseline, the average BMI was 31 kg/m2 and 81% had MetS

Wegovy pens, by contrast, are single-dose devices that should be discarded after one use, so post-use storage is not applicable

Additionally, research using PD models has shown that unusually elevated levels of TNF- and interferon-gamma (IFN-) secretion support the TNF-/Janus kinase/signal transducer and activator of transcription and IFN-/MAPK/extracellular signal-regulated kinase-mediated activation of nuclear factor kappa-B in microglia and astroglia, respectively